Anbio Biotechnology (NNNN) Gross margin 2022–2025
Anbio Biotechnology (NNNN) gross margin by fiscal year — reported gross profit divided by reported revenue.
87.2%FY2025 · since FY2022: 53.4% → 87.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 87.2% | +15.3 pp |
| FY2024 | 71.9% | +21.8 pp |
| FY2023 | 50.1% | -3.3 pp |
| FY2022 | 53.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice